Jim Cramer on DaVita: “Haven’t Seen That Stock Do That Well In This Long”

DaVita Inc. (NYSE:DVA) is one of the S&P 500 stocks that Jim Cramer shared his take on. Cramer highlighted the reason for the company’s rally in February, as he said:

Now, there were a couple non-data center stories, too. The third-best performer in the S&P last month was DaVita. It’s a medical technology company, best known for its kidney dialysis machines. It had a terrible year in 2025, down 24%, but they reported a terrific quarter last month, and the stock caught fire, which is how it finished February up 43%. Haven’t seen that stock do that well in this long. As was the case with Dell, I think this was a situation where the analysts and the investors simply got too negative about the story. So when it turned out that things weren’t as bad as they thought, the stock soared.

Photo by Anna Nekrashevich on Pexels

DaVita Inc. (NYSE:DVA) delivers kidney dialysis treatment through outpatient centers, hospitals, and home-based care, supported by laboratory testing and physician services.

While we acknowledge the risk and potential of DVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than DVA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None.  Follow Insider Monkey on Google News.